consistent use over weeks allows the antioxidant to penetrate the skin's layers, promoting cell turnover and fading discoloration
Im coming from the side of scientists where I need data, he said
Orforglipron (LY3502970), a novel, oral non-peptide glucagon-like peptide-1 receptor agonist: A Phase 1a, blinded, placebo-controlled, randomized, single- and multiple-ascending-dose study in healthy participants
It works by accelerating cell turnover, which can help reduce the appearance of fine lines, wrinkles, and age spots
the efficacy of the combination (known as CagriSema) on weight loss in persons with either overweight and coexisting conditions or obesity is unknown, explained the study authors
That doesnt mean they are inherently dangerous but it does mean we dont fully understand their riskbenefit profile in musculoskeletal injury